Delivery Order SPE2DB20D3101-SPE2DB24FRSM8
Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4,567,372,778 units of ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,665.15 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 25, 2025, with a completion date of February 26, 2025. The contract does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the purchase of 4,567,175,269 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $12,156.98 firm fixed-price delivery order has a completion date of February 6, 2025 and is not designated under any set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the provision of 4,564,949,977 units of 4 mg ondansetron orally disintegrating tablets to the Defense Logistics Agency (DLA). The $4,244.60 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on June 19, 2024 with a completion date of June 20, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,517.76 firm fixed-price delivery order is for the supply of 4,567,331,384 units of ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of February 21, 2025 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $12,751.76 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of 4,564,990,448 units of ondansetron ODT 4 mg tablets to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,626,504 units of 4 mg Ondansetron HCL tablets. The firm-fixed-price delivery order, valued at $18,464.18, has a completion date of December 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of 4,560,801,374 units of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The $9,146.70 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 2, 2023, with a completion date of May 3, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,528.76 contract is for the supply of 4,564,885,759 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, with an ultimate completion date of June 13, 2024. Amerisourcebergen, a large pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- This federal contract award is for the delivery of 4,566,165,480 units of ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $22,056.48, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with a completion date of October 22, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,989.77 firm fixed-price delivery order is for 4,564,689,910 units of ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...